Wall Street analysts predict that Elanco Animal Health (NASDAQ:ELAN) will announce $0.26 earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have provided estimates for Elanco Animal Health’s earnings, with estimates ranging from $0.25 to $0.27. The business is expected to issue its next quarterly earnings report on Thursday, August 8th.
On average, analysts expect that Elanco Animal Health will report full year earnings of $1.10 per share for the current financial year, with EPS estimates ranging from $1.08 to $1.11. For the next financial year, analysts expect that the business will report earnings of $1.29 per share, with EPS estimates ranging from $1.24 to $1.30. Zacks’ earnings per share calculations are an average based on a survey of sell-side research analysts that follow Elanco Animal Health.
Elanco Animal Health (NASDAQ:ELAN) last released its quarterly earnings results on Thursday, May 9th. The company reported $0.25 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.03. The company had revenue of $731.10 million for the quarter, compared to analysts’ expectations of $743.40 million. During the same quarter in the previous year, the company posted $0.33 EPS. The business’s quarterly revenue was down .7% on a year-over-year basis.
Several analysts recently weighed in on ELAN shares. Zacks Investment Research upgraded Elanco Animal Health from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a report on Tuesday, March 26th. Bank of America upgraded Elanco Animal Health from a “neutral” rating to a “buy” rating and set a $30.95 price target on the stock in a report on Monday, March 18th. Morgan Stanley started coverage on Elanco Animal Health in a report on Wednesday, March 13th. They set an “equal weight” rating and a $34.00 price target on the stock. William Blair assumed coverage on Elanco Animal Health in a report on Monday, February 11th. They set a “market perform” rating and a $29.71 price target on the stock. Finally, BMO Capital Markets increased their target price on Elanco Animal Health from $32.00 to $35.00 and gave the stock a “market perform” rating in a research note on Friday, May 10th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $33.47.
In other Elanco Animal Health news, Director R David Hoover bought 20,000 shares of Elanco Animal Health stock in a transaction on Wednesday, March 13th. The shares were acquired at an average price of $31.43 per share, for a total transaction of $628,600.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John P. Bilbrey bought 7,750 shares of Elanco Animal Health stock in a transaction on Monday, May 13th. The stock was acquired at an average price of $32.39 per share, for a total transaction of $251,022.50. The disclosure for this purchase can be found here.
A number of hedge funds have recently added to or reduced their stakes in the business. Sterling Investment Advisors Ltd. purchased a new stake in Elanco Animal Health in the first quarter worth $25,000. Ropes Wealth Advisors LLC purchased a new stake in Elanco Animal Health in the first quarter worth $25,000. Water Island Capital LLC bought a new position in shares of Elanco Animal Health during the 1st quarter worth $27,000. FTB Advisors Inc. bought a new position in shares of Elanco Animal Health during the 1st quarter worth $29,000. Finally, Krensavage Asset Management LLC grew its position in shares of Elanco Animal Health by 0.5% during the 4th quarter. Krensavage Asset Management LLC now owns 200,967 shares of the company’s stock worth $6,336,000 after buying an additional 967 shares in the last quarter.
NASDAQ:ELAN traded up $0.05 during midday trading on Friday, hitting $33.05. 60,541 shares of the company traded hands, compared to its average volume of 7,753,080. Elanco Animal Health has a 12-month low of $28.00 and a 12-month high of $37.61.
Elanco Animal Health Company Profile
There is no company description available for Elanco Animal Health Inc
Further Reading: Technical Analysis
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.